A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

NCT05200442 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

53

Enrollment

OTHER

Sponsor class

Stopped enrollment goal met pending determination of evaluable subjects

Conditions

Colorectal Cancer
Colorectal Adenocarcinoma
Colorectal Cancer Metastatic
Advanced Colorectal Carcinoma
Advanced Colorectal Adenocarcinoma

Interventions

DRUG: VS-6766/avutometinib
DRUG: Cetuximab
OTHER: Pill Diary

Sponsor

University of Chicago

Collaborators

[object Object]